Moors Ine, Benoit Dominique D
Crit Care. 2014 Feb 11;18(1):107. doi: 10.1186/cc13722.
The spectacular improvement in long-term prognosis of patients with hematological malignancies since the 1980s, coupled with the subsequent improvement over the past decade in short- and mid-term survival in cases of critical illness, resulted in an increasing referral of such patients to the ICU. A remaining question, however, is how these patients perform in the long term with regard to survival and quality of life. Here we discuss the present multicenter study on survival beyond 1 year in critically ill patients with hematological malignancies. We conclude with suggestions on how we can further improve the long-term outcome of these patients.
自20世纪80年代以来,血液系统恶性肿瘤患者的长期预后有了显著改善,加之在过去十年中危重症患者的短期和中期生存率也有所提高,导致这类患者转诊至重症监护病房(ICU)的情况日益增多。然而,一个尚存的问题是,这些患者在生存和生活质量方面的长期表现如何。在此,我们讨论目前关于血液系统恶性肿瘤危重症患者1年以上生存期的多中心研究。我们最后提出了关于如何进一步改善这些患者长期预后的建议。